Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
This review outlines the accomplishments and potential developments of targeted alpha (α) particle therapy (TAT). It discusses the therapeutic advantages of the short and highly ionizing path of α-particle emissions; the ability of TAT to complement and provide superior efficacy over existing forms...
Main Authors: | Bryce J. B. Nelson, Jan D. Andersson, Frank Wuest |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/49 |
Similar Items
-
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
by: Romain Eychenne, et al.
Published: (2021-06-01) -
Alpha-Emitting Radionuclides: Current Status and Future Perspectives
by: Matthias Miederer, et al.
Published: (2024-01-01) -
<sup>225</sup>Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic
by: Léa Rubira, et al.
Published: (2023-03-01) -
Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications
by: Bryce J. B. Nelson, et al.
Published: (2023-11-01) -
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
by: Falco Reissig, et al.
Published: (2021-04-01)